Advanced searches left 3/3

Methotrexate - Zenodo

Summarized by Plex Scholar
Last Updated: 08 June 2022

* If you want to update the article please login/register

Efficacy and tolerability of methotrexate at a dose of 15 mg/week and 10 mg/week in patients with pulmonary sarcoidosis.

"The aim of this research is to conduct a comparative review of methotrexate's efficacy and safety in patients with pulmonary sarcoidosis with contraindications to GCS therapy at 10 mg/week and 15 mg/week. " The study involved 44 patients with stage II pulmonary sarcoidosis with contraindications of the use of therapy glucocorticosteroid. Methotrexate was administered in group 2 1 sp;mg/week at a dose of 10 mg/week, but group 2 ; methotrexate was administered at a dose of 15 mg/week at a dose of 15 mg/week. The number of cases of clinical therapy without persistent changes of a fibrous appearance in the lung parenchyma in patients after methotrexate therapy at a dose of 15 mg/week has risen dramatically relative to the same sample of patients after treatment at a dose of 10 mg/week was much higher than the same group of patients after receiving methotrexate at a dose of 10 mg/week bs mg/week a fibrous appearance in the patient's of fibrotic nature in the lung parenchyma in the lung parenchyma a o'sp;ma a dose at a dose of 10  mg/week at a dose at nbsp;mg/week.

Source link: https://zenodo.org/record/6595137

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions

* Please keep in mind that all text is summarized by machine, we do not bear any responsibility, and you should always check original source before taking any actions